European Medicines Agency Approves Moderna Booster Shot for Ages 18 and Over

[Image source=Reuters Yonhap News]

[Asia Economy Reporter Cho Hyun-ui] The European Medicines Agency (EMA) has approved the Moderna booster shot for individuals aged 18 and older who have completed their COVID-19 vaccination.

On the 25th (local time), EMA stated, "It has been analyzed that administering a booster shot at least six months after the second dose of the Moderna vaccine can raise the declining antibody levels."

The dosage for the Moderna booster shot is half that of the first and second doses. EMA added, "Public health agencies in the 27 member countries will officially recommend the booster shot dosage based on regional epidemiological situations."

The side effects of the Moderna booster shot are similar to those experienced after the second vaccine dose. EMA said, "According to current data, side effects including myocarditis that may occur following the booster shot appear only in a small number of people," and emphasized, "Close monitoring is necessary."

The Moderna booster shot is the second to receive EMA approval after Pfizer on the 4th. The U.S. Food and Drug Administration (FDA) has approved booster shots for three vaccines: Pfizer, Moderna, and Janssen.

This content was produced with the assistance of AI translation services.